中红医疗
(300981)
| 流通市值：44.64亿 | | | 总市值：48.71亿 |
| 流通股本：3.57亿 | | | 总股本：3.90亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 935,957,295.81 | 597,585,652.51 | 1,418,309,207.14 | 1,463,012,177.12 |
| 衍生金融资产 | - | 0 | - | - |
| 应收票据及应收账款 | 464,867,630.5 | 430,266,815.3 | 531,122,896.96 | 475,348,144.24 |
| 其中：应收票据 | 3,187,725.22 | 2,789,352.84 | 3,312,049.05 | 3,552,382.09 |
| 应收账款 | 461,679,905.28 | 427,477,462.46 | 527,810,847.91 | 471,795,762.15 |
| 应收款项融资 | 1,380,894.87 | 1,024,680.31 | 1,371,580.66 | 1,016,197.02 |
| 预付款项 | 83,379,055.14 | 48,118,631.65 | 66,812,393.93 | 71,670,379.06 |
| 其他应收款合计 | 27,337,208.86 | 31,820,374.6 | 31,392,540.19 | 28,588,215.69 |
| 存货 | 682,505,295.92 | 576,387,552.98 | 583,456,644.62 | 622,680,865.81 |
| 合同资产 | - | 0 | - | - |
| 一年内到期的非流动资产 | 0 | 157,464,000 | 155,394,041.1 | 257,585,567.38 |
| 其他流动资产 | 858,085,292.61 | 999,796,013.39 | 488,904,557.46 | 405,567,008.89 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 4,810,577,404.45 | 4,569,935,285.28 | 4,558,896,710.38 | 4,641,216,649.71 |
| 非流动资产: | | | | |
| 债权投资 | 14,973,661.09 | 14,737,886.45 | 14,631,725.53 | 14,523,336.99 |
| 其他债权投资 | - | 0 | - | - |
| 长期应收款 | - | 0 | - | - |
| 长期股权投资 | 32,490,105.04 | 32,976,617.91 | 5,831,391.36 | 5,831,391.36 |
| 其他权益工具投资 | 94,307,529.41 | 94,016,691.95 | 96,146,108.47 | 95,356,970.05 |
| 其他非流动金融资产 | 139,167,709 | 139,167,709 | 139,167,709 | 103,167,709 |
| 投资性房地产 | - | 0 | - | - |
| 固定资产 | 1,750,114,317.69 | 1,807,880,707.08 | 1,848,660,596.22 | 1,859,577,921.57 |
| 在建工程 | 97,936,759.92 | 84,090,530.68 | 92,198,796.13 | 100,448,636.22 |
| 生产性生物资产 | - | 0 | - | - |
| 油气资产 | - | 0 | - | - |
| 使用权资产 | 19,570,002.22 | 13,753,874.31 | 9,065,487.73 | 8,978,621.38 |
| 无形资产 | 150,342,823.76 | 153,560,449.39 | 161,509,393.95 | 164,647,841.65 |
| 开发支出 | 233,207.58 | 0 | - | - |
| 商誉 | 149,441,548.15 | 149,441,548.15 | 295,293,771.52 | 295,293,771.52 |
| 长期待摊费用 | 3,586,736.5 | 3,624,518.87 | 4,997,355.12 | 4,791,523.82 |
| 递延所得税资产 | 58,151,721.04 | 58,902,258.96 | 59,255,436.39 | 58,392,227.83 |
| 其他非流动资产 | 108,686,200.58 | 108,272,718.5 | 105,396,928.74 | 109,665,283.13 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 2,619,002,321.98 | 2,660,425,511.25 | 2,832,154,700.16 | 2,820,675,234.52 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 7,429,579,726.43 | 7,230,360,796.53 | 7,391,051,410.54 | 7,461,891,884.23 |
| 流动负债: | | | | |
| 短期借款 | 484,780,817.18 | 391,527,277.31 | 476,742,742.65 | 545,399,386.78 |
| 交易性金融负债 | 15,615,487.6 | 16,082,792.4 | 11,776,200 | 11,776,200 |
| 衍生金融负债 | - | 0 | - | - |
| 应付票据及应付账款 | 591,123,294.58 | 486,538,125.8 | 518,083,488.41 | 489,456,053.78 |
| 其中：应付票据 | 318,247,518.96 | 233,884,319.01 | 196,296,164.01 | 191,600,371.66 |
| 应付账款 | 272,875,775.62 | 252,653,806.79 | 321,787,324.4 | 297,855,682.12 |
| 预收款项 | 0 | 0 | - | - |
| 合同负债 | 74,622,790.93 | 73,797,742.86 | 88,449,641.69 | 79,986,623.14 |
| 应付职工薪酬 | 64,601,968.37 | 69,772,426.12 | 60,856,052.4 | 62,329,460.4 |
| 应交税费 | 6,604,191.87 | 13,070,467.19 | 6,248,141.08 | 9,660,561.63 |
| 其他应付款合计 | 14,109,326.11 | 28,093,052.42 | 10,918,045.34 | 11,170,110.8 |
| 其中:应付利息 | 0 | 0 | - | - |
| 应付股利 | - | 0 | - | - |
| 一年内到期的非流动负债 | 68,954,115.56 | 148,666,729.22 | 315,241,415.47 | 365,653,185.15 |
| 其他流动负债 | 4,594,789.35 | 8,880,799.8 | 7,898,489.65 | 7,611,911.89 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 1,325,006,781.55 | 1,236,429,413.12 | 1,496,214,216.69 | 1,583,043,493.57 |
| 非流动负债: | | | | |
| 长期借款 | 416,975,400 | 330,213,742.94 | 89,019,800 | 91,519,800 |
| 应付债券 | - | 0 | - | - |
| 优先股 | - | 0 | - | - |
| 永续债 | - | 0 | - | - |
| 租赁负债 | 14,707,189.79 | 8,573,902.35 | 5,586,909.12 | 5,453,694.65 |
| 长期应付款 | 0 | 0 | 1,225,471.69 | 1,225,471.69 |
| 长期应付职工薪酬 | 0 | 0 | - | - |
| 预计负债 | 0 | 0 | - | - |
| 递延收益 | 21,432,066.33 | 20,894,673.68 | 21,928,337.34 | 22,301,894.73 |
| 递延所得税负债 | 11,679,224.68 | 13,563,464.52 | 12,536,335.53 | 12,940,379.41 |
| 其他非流动负债 | 0 | 0 | - | - |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 464,793,880.8 | 373,245,783.49 | 130,296,853.68 | 133,441,240.48 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 1,789,800,662.35 | 1,609,675,196.61 | 1,626,511,070.37 | 1,716,484,734.05 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 390,007,800 | 390,007,800 | 390,007,800 | 390,007,800 |
| 其他权益工具 | - | 0 | - | - |
| 优先股 | - | 0 | - | - |
| 永续债 | - | 0 | - | - |
| 资本公积 | 1,715,843,746.94 | 1,715,843,746.94 | 1,715,843,746.94 | 1,715,857,615.94 |
| 减:库存股 | 18,985,800.89 | 18,985,800.89 | 18,985,800.89 | 18,985,800.89 |
| 其他综合收益 | 4,637,380.49 | 4,891,077.57 | 7,931,740.07 | 8,228,762.28 |
| 专项储备 | - | 0 | - | - |
| 盈余公积 | 95,661,783.43 | 95,661,783.43 | 95,661,783.43 | 95,661,783.43 |
| 一般风险准备 | - | 0 | - | - |
| 未分配利润 | 3,305,604,843.72 | 3,286,683,752.02 | 3,424,844,953.44 | 3,406,342,516.63 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 5,492,769,753.69 | 5,474,102,359.07 | 5,615,304,222.99 | 5,597,112,677.39 |
| 少数股东权益 | 147,009,310.39 | 146,583,240.85 | 149,236,117.18 | 148,294,472.79 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 5,639,779,064.08 | 5,620,685,599.92 | 5,764,540,340.17 | 5,745,407,150.18 |
| 负债和股东权益合计 | 7,429,579,726.43 | 7,230,360,796.53 | 7,391,051,410.54 | 7,461,891,884.23 |
| 公告日期 | 2025-04-23 | 2025-04-23 | 2024-10-29 | 2024-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |